NASDAQ:CDT Conduit Pharmaceuticals (CDT) Stock Price, News & Analysis $0.88 -0.12 (-12.01%) (As of 07/2/2024 ET) Add Compare Share Share Today's Range$0.86▼$1.0150-Day Range$1.00▼$3.3452-Week Range$0.63▼$25.00Volume49,628 shsAverage Volume67,109 shsMarket Capitalization$64.92 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Get Conduit Pharmaceuticals alerts: Email Address Ad Behind the MarketsURGENT: Another Country Abandons the DollarVietnam just ditched the US dollar. And they're not alone. BRICS nations are rapidly moving away from the greenback, threatening the stability of your retirement savings. Your wealth could vanish overnight.GET YOUR FREE REPORT HERE >>> About Conduit Pharmaceuticals Stock (NASDAQ:CDT)Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.Read More CDT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDT Stock News HeadlinesJune 26, 2024 | americanbankingnews.comConduit Pharmaceuticals (NASDAQ:CDT) Shares Down 15.2% May 22, 2024 | businesswire.comAstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024July 2, 2024 | Behind the Markets (Ad)AI depends on this... Your retirement could too!Imagine owning a piece of the backbone powering the AI revolution. Wall Street says it's extremely undervalued - a downright steal compared to peers. We call it the "Last Retirement Stock You'll Ever Need."May 15, 2024 | investorplace.comCDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q1 2024March 19, 2024 | finance.yahoo.comConduit Pharmaceuticals Adds Key Leadership PositionsMarch 19, 2024 | globenewswire.comConduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific OfficerMarch 11, 2024 | finance.yahoo.comConduit Pharmaceuticals Opens New Laboratory in UKMarch 11, 2024 | finance.yahoo.comConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubJuly 2, 2024 | Behind the Markets (Ad)AI depends on this... Your retirement could too!Imagine owning a piece of the backbone powering the AI revolution. Wall Street says it's extremely undervalued - a downright steal compared to peers. We call it the "Last Retirement Stock You'll Ever Need."March 11, 2024 | globenewswire.comConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences HubFebruary 28, 2024 | seekingalpha.comConduit Pharmaceuticals: Stellar Management Team, New Business ModelFebruary 15, 2024 | sg.finance.yahoo.comConduit Pharmaceuticals Inc. (CDT)February 13, 2024 | uk.finance.yahoo.comConduit Pharmaceuticals Inc. (CDTTW)January 31, 2024 | finance.yahoo.comConduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceDecember 6, 2023 | wsj.comConduit Pharmaceuticals Inc.November 2, 2023 | finance.yahoo.comConduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare ConferenceOctober 31, 2023 | msn.comKXIN and ICU among pre-market losersOctober 28, 2023 | seekingalpha.comCDT Conduit Pharmaceuticals Inc.October 24, 2023 | uk.investing.comConduit Pharmaceuticals Inc (CDT)October 11, 2023 | finance.yahoo.comConduit Pharma CEO Tapolczay on Biopharma Differentiation, PipelineOctober 11, 2023 | finance.yahoo.comConduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656See More Headlines Receive CDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/02/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CDT Previous SymbolNASDAQ:CDT CUSIPN/A CIK1896212 Webwww.conduitpharma.com Phone760-471-8536FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-540,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-20.19% Debt Debt-to-Equity RatioN/A Current Ratio1.59 Quick Ratio1.59 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-87.93Miscellaneous Outstanding Shares73,830,000Free Float56,487,000Market Cap$64.92 million OptionableNot Optionable Beta2.22 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. David Joszef Tapolczay (Age 65)CEO & Director Comp: $419.8kMr. Adam Sragovicz (Age 54)Chief Financial Officer Comp: $116.67kDr. Joanne M. Holland (Age 49)Chief Scientific Officer Key CompetitorsXOMANASDAQ:XOMAAlimera SciencesNASDAQ:ALIMNkartaNASDAQ:NKTXAtea PharmaceuticalsNASDAQ:AVIRAmarinNASDAQ:AMRNView All Competitors CDT Stock Analysis - Frequently Asked Questions How have CDT shares performed in 2024? Conduit Pharmaceuticals' stock was trading at $4.55 at the beginning of 2024. Since then, CDT shares have decreased by 80.7% and is now trading at $0.8793. View the best growth stocks for 2024 here. Are investors shorting Conduit Pharmaceuticals? Conduit Pharmaceuticals saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 56,800 shares, an increase of 72.6% from the May 31st total of 32,900 shares. Based on an average daily volume of 44,100 shares, the short-interest ratio is currently 1.3 days. Currently, 0.6% of the shares of the company are short sold. View Conduit Pharmaceuticals' Short Interest. When is Conduit Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our CDT earnings forecast. How were Conduit Pharmaceuticals' earnings last quarter? Conduit Pharmaceuticals Inc. (NASDAQ:CDT) posted its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.05) earnings per share for the quarter. How do I buy shares of Conduit Pharmaceuticals? Shares of CDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CDT) was last updated on 7/2/2024 by MarketBeat.com Staff From Our PartnersRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicator...StockEarnings | Sponsored25th AmendmentIt's not surprising that talk of invoking the 25th Amendment (to remove Biden from office) has surfaced.Stansberry Research | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduit Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDT Stock Alerts